Keywords: xenon, takeda, xen401, licensing, accord, canada-based, pharmaceuticals

Xenon and Takeda in XEN401 licensing accord

Article | 16 October 2006

Canada-based Xenon Pharmaceuticals and Japanese drugmaker Takeda say they have entered into an exclusive agreement to develop and commercialize the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Nystatin

Go to drug listing